{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:14:56Z","timestamp":1791296096501,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T00:00:00Z","timestamp":1444608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007333","name":"Alzheimer\u2019s Disease Neuroimaging Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"DOD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007333","name":"ADNI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007333","name":"ADNI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ENIGMA Center","award":["U54 EB 020403"],"award-info":[{"award-number":["U54 EB 020403"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.neurobiolaging.2015.09.018","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T15:11:18Z","timestamp":1445613078000},"page":"26-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials"],"prefix":"10.1016","volume":"37","author":[{"given":"Xue","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.K.","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9317-1137","authenticated-orcid":false,"given":"Adam","family":"Mezher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris A.","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrek P.","family":"Hibar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex D.","family":"Leow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib1","series-title":"Morphometry. Human brain function","author":"Ashburner","year":"2003"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/nimg.2001.0848","article-title":"In\u00a0vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease","volume":"14","author":"Baron","year":"2001","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib4","doi-asserted-by":"crossref","unstructured":"Carmichael OT, Thompson PM, Dutton RA, Lu A, Lee SE, Lee JY, Kuller LH, Lopez OL, Aizenstein HJ, Meltzer CC, Liu Y, Toga AW, Becker, JT. Mapping ventricular changes related to dementia and mild cognitive impairment in a large community-based cohort. IEEE International Symposium on Biomedical Imaging. 2006;315\u2013318.","DOI":"10.1109\/ISBI.2006.1624916"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuroimage.2010.02.064","article-title":"Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative","volume":"51","author":"Chen","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuroimage.2004.01.002","article-title":"An automated algorithm for the computation of brain volume change from sequential MRIs using an iterative principal component analysis and its evaluation for the assessment of whole-brain atrophy rates in patients with probable Alzheimer's disease","volume":"22","author":"Chen","year":"2004","journal-title":"Neuroimage"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2015.09.018_bib7","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1017\/S031716710000562X","article-title":"Imaging biomarkers and their role in dementia clinical trials","volume":"34","author":"Chertkow","year":"2007","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib8","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1097\/00001756-200210280-00022","article-title":"Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment","volume":"13","author":"Chetelat","year":"2002","journal-title":"Neuroreport"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2015.09.018_bib9","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/j.neurobiolaging.2014.05.039","article-title":"Does MRI scan acceleration affect power to track brain change?","volume":"36","author":"Ching","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib10","doi-asserted-by":"crossref","unstructured":"Chou YY, Lepor\u00e9 N, Avedissian C, Madsen SK, Hua X, Jack Jr, CR, Weiner MW, Toga AW, Thompson, PM 2009. Mapping ventricular expansion and its clinical correlates in Alzheimer's disease and mild cognitive impairment using multi-atlas fluid image alignment. SPIE Medical Imaging, February 7\u201312 2009, Lake Buena Vista, Florida.","DOI":"10.1117\/12.812411"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1109\/42.932742","article-title":"Consistent image registration","volume":"20","author":"Christensen","year":"2001","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1006\/nimg.2001.0862","article-title":"A\u00a0unified statistical approach to deformation-based morphometry","volume":"14","author":"Chung","year":"2001","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00004728-199403000-00005","article-title":"Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space","volume":"18","author":"Collins","year":"1994","journal-title":"J.\u00a0Comput. Asst. Tomogr."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib15","series-title":"Bootstrap methods and their application","author":"Davison","year":"1997"},{"issue":"Pt 12","key":"10.1016\/j.neurobiolaging.2015.09.018_bib16","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/brain\/awn278","article-title":"Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study","volume":"131","author":"de Jong","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1602\/neurorx.2.2.348","article-title":"Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease","volume":"2","author":"Dickerson","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib18","first-page":"1","article-title":"Plans under way for Alzheimer's prevention trial","volume":"12","author":"Eastman","year":"2012","journal-title":"Neurol. Today"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib19","series-title":"An introduction to the bootstrap","author":"Efron","year":"1993"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1155\/2009\/836437","article-title":"Applications of neuroimaging to disease-modification trials in Alzheimer's disease","volume":"21","author":"Fleisher","year":"2009","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archneur.57.3.339","article-title":"Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects","volume":"57","author":"Fox","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(01)05408-3","article-title":"Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images","volume":"358","author":"Fox","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jmri.1880070620","article-title":"Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease","volume":"7","author":"Fox","year":"1997","journal-title":"J.\u00a0Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuroimage.2011.01.077","article-title":"Algorithms, atrophy and Alzheimer's disease: cautionary tales for clinical trials","volume":"57","author":"Fox","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1109\/42.640753","article-title":"The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI","volume":"16","author":"Freeborough","year":"1997","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/00004728-199809000-00031","article-title":"Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images","volume":"22","author":"Freeborough","year":"1998","journal-title":"J.\u00a0Comput. Assist. Tomogr."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib28","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.neurobiolaging.2010.05.006","article-title":"Alzheimer's disease neuroimaging initiative special issue","volume":"31","author":"Frisoni","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuroimage.2012.12.052","article-title":"Maximizing power to track Alzheimer's disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features","volume":"70","author":"Gutman","year":"2013","journal-title":"Neuroimage"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2015.09.018_bib30","first-page":"S69","article-title":"Empowering imaging biomarkers of Alzheimer's disease","volume":"36","author":"Gutman","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuroimage.2013.10.067","article-title":"On the interpretation of weight vectors of linear models in multivariate neuroimaging","volume":"87","author":"Haufe","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib33","doi-asserted-by":"crossref","first-page":"421 e3","DOI":"10.1016\/j.jalz.2013.07.003","article-title":"Coalition against Major Diseases\/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease","volume":"10","author":"Hill","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib34","doi-asserted-by":"crossref","first-page":"20954","DOI":"10.1073\/pnas.0906053106","article-title":"Subregional neuroanatomical change as a biomarker for Alzheimer's disease","volume":"106","author":"Holland","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib35","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/hbm.21386","article-title":"Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI","volume":"33","author":"Holland","year":"2012","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib36","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.neuroimage.2012.10.086","article-title":"Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials","volume":"66","author":"Hua","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib37","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.neurobiolaging.2010.04.033","article-title":"Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans","volume":"31","author":"Hua","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib38","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1109\/TMI.2011.2138152","article-title":"Robust brain extraction across datasets and comparison with publicly available methods","volume":"30","author":"Iglesias","year":"2011","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib40","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/WNL.51.4.993","article-title":"Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease","volume":"51","author":"Jack","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib41","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","article-title":"Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment","volume":"52","author":"Jack","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.WNL.0000110315.26026.EF","article-title":"Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD","volume":"62","author":"Jack","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/01.wnl.0000180958.22678.91","article-title":"Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI","volume":"65","author":"Jack","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/01.WNL.0000042480.86872.03","article-title":"MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD","volume":"60","author":"Jack","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib45","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","article-title":"Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease","volume":"133","author":"Jack","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jalz.2010.03.003","article-title":"The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core","volume":"6","author":"Jagust","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib47","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.neuroimage.2005.09.046","article-title":"Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data","volume":"30","author":"Jovicich","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib49","first-page":"493","article-title":"Inverse consistent mapping in 3D deformable image registration: its construction and statistical properties","volume":"19","author":"Leow","year":"2005","journal-title":"Inf. Process. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib50","article-title":"APOE and BDNF polymorphisms moderate amyloid beta-related cognitive decline in preclinical Alzheimer's disease","author":"Lim","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib51","series-title":"Mathematical foundations of elasticity","author":"Marsden","year":"1994"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib52","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib53","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1098\/rstb.2001.0915","article-title":"A\u00a0probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM)","volume":"356","author":"Mazziotta","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib54","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.0000000000000431","article-title":"Amyloid and APOE epsilon4 interact to influence short-term decline in preclinical Alzheimer disease","volume":"82","author":"Mormino","year":"2014","journal-title":"Neurology"},{"issue":"1 Suppl","key":"10.1016\/j.neurobiolaging.2015.09.018_bib55","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.neuroimage.2008.10.043","article-title":"Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls","volume":"45","author":"Morra","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib56","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","article-title":"Within-subject template estimation for unbiased longitudinal image analysis","volume":"61","author":"Reuter","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib57","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.mri.2004.01.078","article-title":"Characterizing changes in MR images with color-coded Jacobians","volume":"22","author":"Riddle","year":"2004","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","article-title":"Apolipoprotein E alleles as risk factors in Alzheimer's disease","volume":"47","author":"Roses","year":"1996","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib59","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0958-1669(94)90091-4","article-title":"APOE is a major susceptibility gene for Alzheimer's disease","volume":"5","author":"Roses","year":"1994","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib60","series-title":"Fundamentals of biostatistics","author":"Rosner","year":"1990"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib61","unstructured":"Ross, J., Thompson, P.M., Tariot, P., Reiman, E.M., Schneider, L., Frigerio, E., Fiorentini, F., Giardino, L., Calz\u00e0, L., Norris, D., Cicirello, H., Casula, D., Imbimbo, B.P. 2012. Primary and secondary prevention trials in subjects at risk of developing Alzheimer\u2019s disease: the GEPARD-AD (genetically enriched population at risk of developing Alzheimer\u2019s disease) studies. CTAD Conference, Monte Carlo, Monaco."},{"issue":"Pt 5","key":"10.1016\/j.neurobiolaging.2015.09.018_bib62","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/brain\/awt065","article-title":"Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease","volume":"136","author":"Ryan","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib64","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0140-6736(93)91709-U","article-title":"Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases","volume":"342","author":"Saunders","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib65","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/awp007","article-title":"MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers","volume":"132","author":"Schuff","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A\u00a0nonparametric method for automatic correction of intensity nonuniformity in MRI data","volume":"17","author":"Sled","year":"1998","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib67","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/35004593","article-title":"Growth patterns in the developing brain detected by using continuum mechanical tensor maps","volume":"404","author":"Thompson","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib68","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.neuroimage.2004.03.040","article-title":"Mapping hippocampal and ventricular change in Alzheimer disease","volume":"22","author":"Thompson","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib69","series-title":"Brain Warping","author":"Toga","year":"1999"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib70","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuroimage.2015.03.026","article-title":"Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease","volume":"113","author":"Vemuri","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib71","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00259-013-2681-7","article-title":"In\u00a0vivo evaluation of a novel tau imaging tracer for Alzheimer's disease","volume":"41","author":"Villemagne","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib72","doi-asserted-by":"crossref","first-page":"202 e7","DOI":"10.1016\/j.jalz.2010.03.007","article-title":"The Alzheimer's disease neuroimaging initiative: progress report and future plans","volume":"6","author":"Weiner","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib73","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jalz.2015.04.005","article-title":"Impact of the Alzheimer's disease neuroimaging initiative, 2004\u20132014","volume":"11","author":"Weiner","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"1\u00a0Suppl","key":"10.1016\/j.neurobiolaging.2015.09.018_bib74","first-page":"S1","article-title":"The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception","volume":"8","author":"Weiner","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.09.018_bib75","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.neuroimage.2009.12.007","article-title":"Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global normalization: an illustration in ADNI 3 T MRI data","volume":"50","author":"Yushkevich","year":"2010","journal-title":"Neuroimage"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015004753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015004753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:24:15Z","timestamp":1759317855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458015004753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":73,"alternative-id":["S0197458015004753"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.09.018","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}